That’s a mysterious headline, right? The pitch we’re looking at today is from Dave Lashmet at Stansberry, who’s selling his Stansberry Venture newsletter for $5,000 — and the carrot he’s dangling to get you to subscribe is this “most disruptive biotech discovery” … which, it turns out, is a form of radiation therapy that, in […]
Articles
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info
Comments
Any chance it could be Theralase? Not radiotherapy but photodynamic compounds and lasers. Two patients cancer free at 54...
Check this interview by VRAY CEO: https://stocknewsnow.com/showcommentary.php?newsartid=ANEWSID15122015100001&title=...
$CLRB Dr. KSS I understand the frustration but it really has not been that long and does it not deserve a call to ...
$RXDX long Layman question. I'm curious how the following passage squares with the otherwise positive results: "The pat...
For $CLRB longs, would-be longs, and people who attended Friday's call: Pursuant to what we discussed I reached out to J...
$TRIL, #CD47: A significant scientific discovery with potential clinical implications: Stanford researchers devise ne...
$ATNM As we all know by now, today was a bad day for ATNM. Once again I think it was the result of investors expecting...
HN, this is where the youth and vigor of the patient come in... A younger patient (down to a point) may be able to toler...
DBMD, $ATNM Forgive the copy and paste.... But Note my edits regarding [conventional radiotherapy concepts]. When e...
Any thoughts on this company Progenics Pharma (PGNX)? Deals with Salix and Valeant for Relistor which treats opioid indu...
a very good article. I appreciated learning about the updates to radiotherapy since I was last a patient and specificall...
Hello, Accuray makes radiotherapy machine which they call "tomotherapy". This machines treats cancer patients. The mai...